Expanded use case analysis for rapid antigen diagnostics for SARS-CoV-2 mitigation. Phase 2 results from the ACT-Accelerator SARS-CoV-2 rapid antigen testing modelling consortium.
Tag: modelling
Expanded use case analysis for Phase 1 Results from the ACT-Accelerator SARS-COV-2 Rapid Antigen testing Modelling Consortium Rapid antigen diagnostics for SARS-CoV-2 mitigation.